Protalix Biotherapeutics Inc (PLX)
EBITDA Margin
32.60%
TTM · Period ending:
PLX EBITDA Margin
Latest reported32.60%period ending
Latest reported32.60%period ending
PLX EBITDA Margin (0.00% → 32.60%)
Annual ebitda margin
High-resolution chart · PNG
PLX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -5.5968% | |
| 12.21% | |
| 19.753% | |
| -22.6332% | |
| -49.395% | |
| 7.0749% | |
| -15.8942% | |
| -49.9445% | |
| -340.6158% | |
| -250.038% | |
| -485.2658% | |
| -166.3786% | |
| -204.7859% | |
| -23.0246% | |
| -392.3205% | |
| -238.6428% | |
| -7,726.5464% | |
| 0% | |
| 0% | |
| -5,994.6667% | |
| -3,652% | |
| -533.4884% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -18.3685% | |
| -12.0956% | |
| 0% | |
| 0% |